COPD and asthma: the effect of glucocorticosteroid therapy on tolerance to physical activity

A. A. Denisenko, O. V. Dudina, V. I. Trofimov (St. Petersburg, Russian Federation)

Source: Annual Congress 2005 - COPD - treatment III
Session: COPD - treatment III
Session type: Thematic Poster Session
Number: 1962
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. A. Denisenko, O. V. Dudina, V. I. Trofimov (St. Petersburg, Russian Federation). COPD and asthma: the effect of glucocorticosteroid therapy on tolerance to physical activity. Eur Respir J 2005; 26: Suppl. 49, 1962

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bronchodiator therapy in COPD: physiological effects
Source: Breathe 2008; 4: 342-344
Year: 2008

Omalizumab improves asthma control in patients receiving high-dose ICS and multiple other controller therapies and who have continuing impairment of lung function and asthma symptoms
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007


Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 261s
Year: 2001

Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Addition of theophylline to standard inhalatory therapy in patients with stable COPD: effects on exercise tolerance
Source: Eur Respir J 2006; 28: Suppl. 50, 215s
Year: 2006

The effect of high dose bronchodilators on cardiac function in elderly people with severe COPD or asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 407s
Year: 2002

The effect on mortality of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A focus on the frequent exacerbator phenotype
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015

The effects of adding in erdosteine on the routine bronchodilator therapy in moderate and severe COPD patients
Source: Annual Congress 2006 - COPD therapy
Year: 2006


Pulmonary function test changes after cessation of inhaled corticosteroid therapy in asthma patients
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012


The effects of physical activity coaching in patients with COPD after an acute exacerbation
Source: International Congress 2014 – Exercise training and physical activity in patients with COPD
Year: 2014


Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function
Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma
Year: 2020




Evaluating the effects of inhaled corticosteroid on insulin sensitivity in asthmatic patients
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016


Influence of combined antiasthmatic basic therapy on hyperinflation in patients with severe bronchial asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 553s
Year: 2007

Effects of a single inhaled budesonide/formoterol dose on glucocorticoid receptor activity in sputum of COPD patients
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016


The effect of different bronchodilator drugs on pulmonary function tests, exercise capacity and quality of life in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 515s
Year: 2005

Effect of oral prednisolone on the bronchoprotective effect of formoterol in patients with persistent asthma
Source: Eur Respir J 2001; 17: 374-379
Year: 2001



Smoking, sputum cell counts, diffusion capacity and hyperinflation predict beneficial effects of long-term inhaled corticosteroids (ICS) on FEV1-decline in patients with mild-to-moderate COPD
Source: Annual Congress 2010 - COPD: management
Year: 2010

Physical activity and the use of COPD medication
Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases
Year: 2015


The effects of physical activity on asthma incidence
Source: Annual Congress 2009 - Epidemiology of atopy and asthma
Year: 2009

Longitudinal change in bronchial responsiveness in patients with cough variant asthma and the effect of inhaled corticosteroids
Source: Eur Respir J 2004; 24: Suppl. 48, 587s
Year: 2004